OUR TECHNICAL KNOW


BRCA 1/2 · TEST BREAST CANCER GENE

The risk of a woman developing breast or ovarian cancer is greatly increased if inherited a harmful mutation in BRCA1 or BRCA2.

The test is done with a simple blood test and allows, in case of positive results, follow-up action and / or early detection and personalized, both the patient and their relatives. This test helps partner counseling before assisted reproductive treatment.


Assisted Reproduction Techniques

TEST OF REMAINS ABORTIFACIENTS

Studies of fetal remains by array CGH. 50% of miscarriages in the first trimester of pregnancy are due to chromosomal abnormalities. The array CGH is a molecular technique that allows direct analysis of aneuploidy for chromosomes 24. The study of markers in maternal blood can rule out misdiagnosis for possible maternal contamination.

Results in a week, 98.6% accuracy, does not require cultivation. Higher resolution than that obtained in the conventional karyotype


TEST DE receptividad endometrial

To assess the status of women endometrial receptivity to prevent implantation failure.

It is a diagnostic method, developed by IREG that identifies the window of implantation and result set based on a transfer of personal embiones. 24% of patients are unreceptive, in 88% of these cases, a 2nd bipsia determine the window of implantation and therefore, the period in which the patient is receptive. Indicated in women with implantation failure with good quality embryos.


TEST OF MALE INFERTILITY

Test or male infertility Sperm Aneuploidy (SAT) is a diagnostic test for the study of male infertildad. In couples where a male factor underlying the risk of transmitting chromosome to the offspring of sperm abnormalities procentes increases.

Assesses the presence of alterations in the number of chromosomes (aneuploidy and diploidías) in sperm. Aid partner counseling before assisted reproductive treatment.




DPG · PGD FOR MONOGENIC DISEASES

Genetic diagnosis made early in the embryo before transfer to the uterus for couples with a family of high risk for monogenic diseases or personal history. The previous analysis of DNA from each embryo to select and transfer to the womb those who have not inherited the disease.

Ability to perform PGD for any monogenic disease. Available a panel of common diseases whose diagnosis is immediate. Possibility of making DGP + PGs in the same biopsy.


PGS · TO CHROMOSOME ABNORMALITIES

It is an embryonic genetic analysis that is performed during IVF treatment for detecting abnormalities in chromosome number. Our technology, based CGH arrays, allows study of 24 chromosomes is to rule embryonic aneuploidy before transfer to the uterus.

Higher rate of implantation and pregnancy with a larger number of informative embryos (98%), using a single embryonic cell. Suitable for women of advanced maternal age, recurrent implantation failure, repeat abortions and male factor.

GENETIC TEST CGT CARRIER

40,000 study DNA variants associated with over 600 diseases. To determine the risk of having a child with a genetic disease by analyzing DNA variants 40,000 and more than 600 genetic diseases.

Possibility of offering patients a test to infertility clinics receiving a donation of sperm or eggs. The most common monogenic diseases such as cystic fibrosis, spinal muscular atrophy, X-Fragil Beta thalassemia, etc.


CONTACT our specialists   Schedule your appointment


IREGA PUEBLA

IREGA is home of a team of experts in the care of fertility, willing make your dream of having a baby reality

IREGA ACAPULCO

  • (744) 484 4471 · (744) 488 1114
  • contact@iregaacapulco.com.mx
  • Cerrada de Cumbres #104 Fracc. Farallón, C.P. 39690

IREGA CANCÚN

  • (998) 802 1516 · (998) 206 1515
  • contact@iregacancun.com.mx
  • Hospital Galenia Planta Baja Av. Tulum Lote 01 Maza. 01 SM 12 Fracc. Sta. Maria Sike Esq. Nizuc, C.P. 77505

IREGA PUEBLA

  • (222) 225 1091 · (222) 225 1103
  • contact@iregapuebla.com.mx
  • Paseo de las Ramblas No.2A Primer piso Desarrollo Atlixcáyotl, C.P. 72197.

USA & CANADA

  • USA 011 52 (744) 484 4471 · 011 52 (744) 488 11 14
  • CANADA 01 52 (744) 484 4471
  • adanoliveros52@gmail.com.mx